Soleno Therapeutics Inc (SLNO) P/E ratio is 27.47
Soleno Therapeutics Inc (SLNO) P/E ratio is 27.47. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full SLNO research page for quote, filings, and the rest of the model. This satellite exists so “Soleno Therapeutics Inc P/E ratio” can rank with the actual number, then send you to /stock/slno.